MCH ADVISORY EQUITY RESEARCH
Institutional research — not investment advice ← Library
KHC HOLD REF $25 PW TARGET $23 (-9% vs spot · 12m PWEV) -8% Single-name research · 8 July 2026
Equity ResearchConsumer Staples · Packaged Foods & Meats
KHC

Kraft Heinz Co (KHC)

HOLD. 12-month probability-weighted target $23 (-8% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

Verdict
HOLD
Triangulated fair value $25 (-2% vs spot · triangulated FV)
Reference
$25
Close · 8 July 2026
PW Target
$23 (-9% vs spot · 12m PWEV) -8%
Probability-weighted
Horizon
12 mo
MCH Advisory
$25 (-2% vs spot · triangulated FV)
Fair value
$23 (-9% vs spot · 12m PWEV)
Scenario PWEV
12.1x
Forward P/E
$31B
Market cap
$21–$27
52-week range
Contents

Rating: HOLD

HOLD (5-tier) · balance-sheet repair · conviction: low

Metric Value
Current Price $25
Triangulated Fair Value $25 (-2% vs spot · triangulated FV)
12-mo Scenario PWEV $23 (-9% vs spot · 12m PWEV)
Forward P/E 12.1x
Market Cap $31B
52-Week Range $21–$27

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).


Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Investment Committee Summary

Rating HOLD · HOLD (5-tier)
Classification · conviction balance-sheet repair · low
Triangulated fair value $25 (-2% vs spot · triangulated FV)
12-mo scenario PWEV $23 (-9% vs spot · 12m PWEV)
Next catalyst 2026-02-25 — FY2026 guidance + goodwill/brand-impairment review
Primary thesis-break Organic net sales growth (YoY) < -0.02 (2 consecutive prints)

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Rating Bridge

Rating = HOLD because:

  • Probability-weighted scenario value implies -9% vs spot
  • Monte Carlo median implies -17% vs spot
  • DCF fair value implies -71% vs spot — but this is terminal-value sensitive (exit-multiple $7 vs Gordon $22, 197% apart), so it carries less weight
  • Bear case (Structural — GLP-1 / Private-Label Erosion) downside is -61% vs spot
  • Net: reward/risk of 0.0× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Investment Thesis

At $23.62 KHC trades on roughly 11x forward earnings and yields close to 7%, a valuation that prices packaged food as a structurally shrinking annuity: the market assumes volume leaks to private label and GLP-1 appetite suppression, with price/mix unable to hold the line. The engine's probability-weighted target of $22.99 broadly agrees. It sits the base case at ~2% growth and a 13.2% margin on a median 11.3x multiple, but carries a 24% weight on structural erosion whose target lands below the 52-week low of $20.66. The rating is HOLD because the weighted view is within 3% of spot; the near-7% yield pays the investor to wait, yet the balance sheet carries $17.66B of net debt against a 10% five-year revenue CAGR embedded nowhere. Free cash flow covers the dividend today (FY2025 operating cash flow $4.462B versus $1.898B paid), which anchors the downside. The single most damaging risk is that volume erosion proves structural rather than cyclical, forcing margin and multiple to compress together toward the $9.86 impairment case.

The dashboard below is the whole argument on one page: spot ($25) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Integrated dashboard. The five valuation anchors bracket the $25 spot from $7 to $35 — stretched — spot sits above the skeptical blend.
Integrated dashboard. The five valuation anchors bracket the $25 spot from $7 to $35 — stretched — spot sits above the skeptical blend.

Anti-Thesis (The Real Bear Case)

The highest-probability bear is not a crash but slow structural bleed. GLP-1 adoption trims centre-of-store calorie demand while private label, now backed by better retailer execution and quality, takes share in categories where Kraft Heinz's brands no longer command a premium. Price/mix, the lever that protected margin through the inflation years, reverses as retailers push back and elasticity returns. Volume falls low-single-digits, and each year of negative organic growth de-rates the multiple further because the terminal value keeps shrinking. On $17.66B of net debt, even a modest EBITDA decline lifts leverage toward the dividend's breaking point. The 7% yield then reads as a warning, not a reward, and the stock grinds toward the $9.86 structural target.

Key Debate

Gross Margin explains 57% of Monte Carlo outcome variance — the single variable that decides which side is right.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.37 vs analyst floor +0.00 → delta +0.37 (n=18 mgmt / 13 Q&A; 48th pctile across the S&P book, z -0.1).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

Quarter Mgmt Analyst Delta
2026Q1 +0.37 +0.00 +0.37
2025Q4 +0.30 +0.17 +0.13
2025Q3 +0.24 +0.20 +0.04
2025Q2 +0.41 +0.13 +0.28

News (last 365d, 1000 articles): avg ticker sentiment +0.11 (bullish 12% / bearish 3%)

Scenario Analysis

The tree runs from a structural 'Structural — GLP-1 / Private-Label Erosion' downside ($10) to a 'Bull — Margin Recovery / Re-Rate' bull case ($40); the probability-weighted blend (PWEV $23) is -9% versus spot.

Scenario Probability Target Return vs spot
Structural — GLP-1 / Private-Label Erosion 24% $10 -61%
Volume / Cost Recession 18% $19 -26%
Base — Price/Mix Offsets Volume 32% $26 +1%
Growth — Snacking + Premiumization 18% $33 +29%
Bull — Margin Recovery / Re-Rate 8% $40 +58%
Probability-Weighted (PWEV) $23 -9%

Scenario rationale — what each probability buys (the driver path behind every target):

  • Structural — GLP-1 / Private-Label Erosion (24%, $10). Structural impairment — GLP-1 / private-label erosion: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 9.86; probability: 0.24.
  • Volume / Cost Recession (18%, $19). Cyclical downturn — packaged-food volume + price/mix vs private-label + GLP-1 + input costs weakens for 1–2 years before normalising. Drivers — implied_target: 18.81; probability: 0.18.
  • Base — Price/Mix Offsets Volume (32%, $26). Mid-cycle — normalised packaged-food volume + price/mix vs private-label + GLP-1 + input costs; disciplined capital allocation; steady returns. Drivers — implied_target: 25.48; probability: 0.32.
  • Growth — Snacking + Premiumization (18%, $33). Upside — snacking + premiumization + margin recovery lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 32.72; probability: 0.18.
  • Bull — Margin Recovery / Re-Rate (8%, $40). Upside tail — sustained tight conditions or a structural re-rate on snacking + premiumization + margin recovery. Drivers — implied_target: 39.91; probability: 0.08.
Five-scenario tree. Probability-weighted targets around the $25 spot; PWEV $23 (-9% vs spot · 12m). the payoff shows modest negative expectancy — downside mass dominates (range <img src=
Five-scenario tree. Probability-weighted targets around the $25 spot; PWEV $23 (-9% vs spot · 12m). the payoff shows modest negative expectancy — downside mass dominates (range $10–$40)

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Method Basis Fair Value vs Spot
Monte Carlo median (Student-t + regime) multiple $21 -17%
Peer P/E re-rate multiple $35 +37%
Peer EV/Revenue re-rate multiple $29 +16%
Scenario PWEV multiple $23 -9%
DCF (5-year + terminal) cash flow + terminal × $7 -71%
Triangulated (weighted) $25 -2%

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

DCF excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $21 and 35% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (57% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

Monte Carlo distribution. Median $21; P(price > current) 35%. P10–P90: <img src=
Monte Carlo distribution. Median $21; P(price > current) 35%. P10–P90: $10–$38.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 8.0%, 9x terminal FCF multiple → $7. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Independent DCF. WACC 8.0%, 9x terminal → $7.
Independent DCF. WACC 8.0%, 9x terminal → $7.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 16.56x) implies $35. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Cross-sectional peer benchmarking. Peer-median fwd P/E 16.56x → $35; EV/Rev re-rate → $29.
Cross-sectional peer benchmarking. Peer-median fwd P/E 16.56x → $35; EV/Rev re-rate → $29.

Across all anchors the spread is 118% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Segment Revenue Mix Growth Op margin EBIT Multiple Capex % Tag
Packaged Foods $25.0B 100% 2% 13% $3.3B 11x 4% ESTIMATE
EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed).

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Dimension Assessment
driver packaged-food volume + price/mix vs private-label + GLP-1 + input costs
net_debt_or_cash_b -17.66

Capital intensity & shareholder returns (ESTIMATE)

Dimension Assessment
capex_pct_revenue 0.04
div_yield 0.0697

Structural risk vs optionality (INFERENCE)

Dimension Assessment
downside GLP-1 / private-label erosion
upside snacking + premiumization + margin recovery

Industry Context — Consumer Staples — Food Bev

This name sits in the Consumer Staples — Food Bev as a packaged_food. packaged-food volume + price/mix vs private-label + GLP-1 + input costs Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: KO (beverages) · PEP (beverages) · MNST (beverages) · MDLZ (packaged_food) · KDP (beverages) · HSY (packaged_food) · KHC (packaged_food) · GIS (packaged_food) · HRL (packaged_food) · MKC (packaged_food) · SJM (packaged_food) · CAG (packaged_food)

Shared state Capex path House view This name implies
Structural — GLP-1 / Private-Label Volume Hit 40% 42%
Mid-Cycle — Price/Mix Offsets Volume 33% 32%
Upside — Premiumization / EM Growth 27% 26%

Mapping note: name-level 'Structural — GLP-1 / Private-Label Erosion' (24%) + 'Volume / Cost Recession' (18%) map to cluster Structural — GLP-1 / Private-Label Volume Hit (42%); name-level 'Growth — Snacking + Premiumization' (18%) + 'Bull — Margin Recovery / Re-Rate' (8%) map to cluster Upside — Premiumization / EM Growth (26%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Structural — GLP-1 / Private-Label Volume Hit () — this name implies 42% vs the cluster house view of 40% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The staples_food_bev cycle is the shared macro driver. Driver — food & beverage volume + price/mix vs private-label + GLP-1 + input costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

Year Revenue Op income − Capex + D&A FCF PV(FCF)
FY+1 $25B $3B $1B $1B $2B $2B
FY+2 $26B $3B $1B $1B $2B $2B
FY+3 $27B $4B $1B $1B $3B $2B
FY+4 $27B $4B $1B $1B $3B $2B
FY+5 $28B $4B $1B $1B $3B $2B
Terminal $3B × 9x $16B

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 8.0% · Σ PV(FCF) $10B + PV(terminal) $16B = EV $27B; + net cash → equity $9B ÷ diluted shares 1.21B = $7/share (exit-multiple terminal).

  • Gordon (perpetuity-growth) terminal at 2.5% → $22/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
  • Incremental ROIC on the forecast capex ≈ 7% vs WACC 8% → below WACC — the incremental build is value-dilutive.

Peer set

Peer EV/Rev Fwd P/E Growth Op margin
MDLZ 2.51x 20.2x 2% 9%
HSY 3.389x 21.32x 2% 21%
TSN 0.501x 12.92x 2% 4%
GIS 1.728x 10.85x 2% 19%
Median 2.1189999999999998x 16.56x

Peer-median fwd P/E → $35; EV/Rev → $29.

Weighted fair-value math

Anchor Value Weight Contribution
Scenario PWEV $23 50% $11
Monte Carlo median $21 30% $6
Peer P/E $35 20% $7
Triangulated 100% $25

Sensitivity

DCF/share — WACC × terminal multiple

WACC \ Term× 6.3x 7.6x 9.0x 10.3x 11.7x
6% $5 $7 $9 $11 $14
7% $4 $6 $8 $10 $13
8% $3 $5 $7 $9 $11
9% $3 $5 $7 $8 $10
10% $2 $4 $6 $8 $10

DCF/share — revenue CAGR Δ × op-margin Δ

CAGRΔ \ MgnΔ -3.0pp -1.5pp +0.0pp +1.5pp +3.0pp
-3.0pp $0 $2 $5 $7 $9
-1.5pp $1 $4 $6 $9 $11
+0.0pp $2 $5 $7 $10 $13
+1.5pp $3 $6 $9 $12 $14
+3.0pp $4 $7 $10 $13 $16

Tornado — DCF/share swing by driver (widest first)

Driver Low High Swing
Op margin ±3pp $2 $13 $11
Revenue CAGR ±3pp $5 $10 $6
Terminal × ±15% $5 $9 $4
Capex intensity ±15% $6 $9 $3
WACC ±1pp $7 $8 $2

Company lever — SoP/share vs Packaged Foods multiple (AI re-rating) (base 11x)

Multiple 7.7x 9.3x 11.0x 12.6x 14.3x
SoP/share $146 $179 $214 $248 $283

Consensus & Market Expectations

Reference Value
Street target (mean) $24 (-6% vs spot · street)
House target $23 (-3.2% vs street)
Sell-side coverage 19 analysts (SB 0 / B 1 / H 14 / S 0 / SS 4; net score -0.18)
Consensus FY EPS $2.09; house in-line (-0.1%)
Consensus FY revenue $24.6B; house above (+3.9%)

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Balance Sheet & Liquidity

Metric Value
Net debt $17.5B — highly levered
Net debt / EBITDA 3.04x
Interest coverage (EBIT / interest) -4.8x
Current ratio 1.15x
Cash & ST investments $3.7B

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Metric Value
Free cash flow $3.7B
Buybacks / dividends $0.4B / $1.9B
Total shareholder yield 7.6%
Payout as % of FCF 63.8%
Reinvestment (capex / OCF) 18.0%
SBC as % of FCF 2.6%
Allocation stance balanced

Free-Cash-Flow Quality

Metric Value
FCF margin 14.6%
FCF conversion (FCF / net income) -62.6%
FCF yield 12.0%
Capex intensity (capex / revenue) 3.2%
FCF − SBC (diagnostic) $3.6B
Capex split (maint / growth) 70% / 30% — Capital-light packaged food - capex ~$0.8-1.05B on $25B revenue (~3-4%). The bulk is maintenance/efficiency of existing plants; the modest growth slice is capacity/automation. D&A runs near capex, consistent with a low-reinvestment, cash-return profile.

Accounting quality: SBC 0.4% of revenue; cash conversion (OCF/NI) -76% — cash-backed.

Catalyst Calendar

  • 2026-02-25 (~-133d) — FY2026 guidance + goodwill/brand-impairment review (authored)
  • 2026-05-06 (~-63d) — Potential portfolio separation / strategic-review outcome (split of grocery vs global brands) (authored)
  • 2026-07-29 (~21d) — Quarterly earnings — est. EPS $0.53 (AV EARNINGS_CALENDAR)
  • 2026-08-04 (~27d) — Dividend coverage / capital-allocation update (authored)

Forecast Track Record

  • EPS surprise: beat 100.0% of the last 8 quarters; average surprise +7.1%.

Competitive Moat

Narrow moat. Kraft Heinz's brand equity has narrowed to a fragile moat as private label closes the quality gap; the falsifiable claim is that if North America volume/mix drags organic growth by more than ~3pp for two quarters, the brands no longer command a premium and the ~11x multiple should compress toward the ~6-9x distressed/private-label floor rather than mean-revert to a staples multiple.

Moat sources:

  • A portfolio of legacy #1/#2 brands (Heinz, Kraft, Philadelphia, Oscar Mayer) with residual shelf presence and scale in procurement/distribution
  • Retail scale and category-captain relationships in centre-of-store - a distribution advantage that is eroding as retailers back private label
  • NO pricing-power moat: elasticity has returned and private label has closed the quality gap in many core aisles (brand equity impairment, literal write-downs)
  • Heinz internationally retains stronger brand equity than the US grocery portfolio - the moat is uneven, not uniform
Issue Probability Valuation sensitivity Horizon
US 'ultra-processed food' scrutiny / MAHA-style labelling, additive and SNAP-eligibility rules medium (~40%) medium - directly targets centre-of-store processed categories, ~5-7% of FV 12-24m
Sodium/added-sugar reformulation mandates and front-of-pack warning labels medium (~35%) medium - reformulation cost + volume drag on core SKUs, ~3-5% of FV 12-24m

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario Macro assumption Key risk
Structural — GLP-1 / Private-Label Erosion Structural demand shift - GLP-1 trims centre-of-store calorie demand while higher-quality private label takes share and elasticity returns Persistent negative volume with price/mix reversing, de-rating the multiple to a private-label floor while $17.66B net debt lifts leverage toward the dividend's breaking point
Volume / Cost Recession Cyclical consumer downtrade plus input-cost squeeze for 1-2 years before normalising Volume decline and margin compression to ~11.8% coinciding, tightening dividend cover
Base — Price/Mix Offsets Volume Mid-cycle - price/mix offsets flat-to-soft volume, margin normalises at ~13.2%, FCF covers the dividend A quietly shrinking volume base making the ~7% yield a value trap rather than a compensated wait
Growth — Snacking + Premiumization Snacking and premiumisation mix lift organic growth to ~4.5% and margin to ~14.5% Innovation and premiumisation failing to scale against private-label pressure in the core portfolio
Bull — Margin Recovery / Re-Rate Sustained margin recovery (cost programme + mix) earns a quality re-rate back toward a staples multiple The re-rate needing the market to re-believe the brand equity that impairments have already questioned

What the Market Is Pricing In

At the current price, the market pays 12.1× forward EPS, vs the house DCF terminal 9.0×, and a peer median 16.56×. The house DCF sits 71% below spot, so the market is pricing in more than the house case — roughly 2.6pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily growth-driven.

Metric Consensus House Importance
Revenue 24.6 25.5 High
EPS 2.1 2.1 Medium
Target price 23.7 23.0 Medium

Peer Quality & Weighting

Peer Fwd P/E Growth Op margin Quality Weight cap
MDLZ 20.2× 2% 9% broad 25%
HSY 21.32× 2% 21% broad 25%
TSN 12.92× 2% 4% direct 100%
GIS 10.85× 2% 19% direct 100%

Quality-weighted forward P/E: 13.7× (simple median 16.56×). Direct peers count 100%, segment 50%, broad 25%.

Valuation-anchor screen: DCF (exit) (excluded (>3× or <0.3× spot)). Anchor median 22.0. Extreme/excluded anchors carry no headline weight.

Historical-range cross-check: 52-week range $21–$27, centre $24 (-6% vs spot); spot sits at the 69th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Metric Value
Upside to triangulated FV $25 (-2% vs spot · triangulated FV)
Downside to bear case (Structural — GLP-1 / Private-Label Erosion) $10 (-61% vs spot · bear scenario)
Reward/risk ratio 0.0×
Margin of safety (FV vs spot) -2%
P(price > spot) — Monte Carlo 35%

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Margin Recovery / Re-Rate): $40.

Assumption Register

Assumption Value Used in Source
WACC 8.0% DCF discount rate estimate (CAPM)
Terminal multiple DCF exit value estimate (peer-anchored)
Terminal growth 2.5% DCF Gordon terminal estimate
SBC dilution 0.0%/yr PWEV, MC, DCF (charged once) estimate (from SBC/rev)
EPS basis consensus forward EPS (broker-adjusted, non-GAAP) all forward P/E & scenario multiples definition

Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (11.0); Revenue CAGR ±3pp (6.0); Terminal × ±15% (4.0); Capex intensity ±15% (3.0); WACC ±1pp (2.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Input Value Type Source Confidence Used in
Revenue TTM $25.0B reported fact 10-K/10-Q via AV High Forecast base, EV/Rev
FY+1 guided revenue $25.5B company guidance Company guidance Medium Forecast, SoP
Consensus FY EPS $2.0926 consensus estimate Sell-side consensus via AV Medium Variant perception
Diluted shares 1.206B reported fact 10-K via AV High Market cap, per-share
Net debt / cash $17.544B reported fact Balance sheet via AV High EV, DCF equity bridge
WACC 8.0% house estimate CAPM (beta/rf) Medium DCF discount rate
Terminal multiple house estimate Peer/historical range Medium DCF exit value
Terminal growth 2.5% house estimate Long-run GDP+ Medium DCF Gordon terminal

Source Log

Source Type Date Used for Reference
Alpha Vantage — GLOBAL_QUOTE / OVERVIEW market data 2026-07-08 Price, market cap, EV, 52-week range, forward P/E Alpha Vantage 2026-06-26
Company income statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Revenue, gross/operating margin, EBIT, interest expense INCOME_STATEMENT / latest annual
Company balance sheet (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Cash, debt, net debt, leases, equity, coverage BALANCE_SHEET / latest annual
Company cash-flow statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Operating cash flow, capex, FCF, buybacks, dividends, SBC CASH_FLOW / latest annual
Company earnings releases via Alpha Vantage reported fact 2026-07-08 Reported EPS, surprise history EARNINGS / quarterly
Sell-side consensus via Alpha Vantage consensus estimate 2026-07-08 Forward revenue/EPS consensus, analyst count EARNINGS_ESTIMATES
Earnings calendar via Alpha Vantage market data 2026-07-08 Next earnings date, catalyst timing EARNINGS_CALENDAR
Company guidance company guidance 2026-07-08 FY guided revenue / non-GAAP EPS basis company guidance / earnings call
MCH segment model (from filings & disclosures) house estimate 2026-07-08 Segment revenue, margins, multiples, AI decomposition company_context (authored, tagged)
MCH qualitative analysis inference 2026-07-08 Moat, regulatory risk, scenario macro, catalysts company_context enrichment (authored)
MCH investment thesis & falsification triggers house estimate 2026-07-08 Thesis, anti-thesis, thesis-break signals authored §5.3

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Load-Bearing Assumptions

DCF: WACC 8%, terminal multiple 9×, FY+5 revenue $28B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

  • Organic net sales growth (YoY) < -0.02 (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). Two straight quarters of organic sales down more than 2% would confirm volume loss is running below the base path and toward the structural-erosion case, not a transient destock.
  • Adjusted operating margin < 0.118 (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). Margin holding below 11.8% for two prints would signal input-cost or promotional pressure consistent with the Volume/Cost Recession path rather than the 13.2% base.
  • North America volume/mix contribution to organic growth < -0.03 (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). Volume/mix dragging organic growth by more than 3pp in the core North America base would indicate private-label and GLP-1 substitution rather than deliberate price-led mix management.
  • Net leverage (net debt / adjusted EBITDA) > 3.5 (single event → Structural — GLP-1 / Private-Label Volume Hit). Leverage breaching 3.5x on falling EBITDA would pressure the ~7% dividend and the investment-grade rating, removing the balance-sheet support the base case assumes.
  • Dividend action = cut or omission (single event → Structural — GLP-1 / Private-Label Volume Hit). A dividend cut would be a discrete admission that free cash flow no longer covers the payout, validating the structural rather than cyclical reading of the demand shortfall.

Fact / Inference / Speculation

  • FACT: Spot $25; 52-week range $21–$27; engine rating HOLD; base-case target $23 (-9%). (source: Alpha Vantage 2026-06-26, 8 July 2026)
  • INFERENCE: Triangulated FV $25 (-2% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
  • SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Recommendation: HOLD

Balanced: triangulated fair value $18 (-30% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin — a fundamental call.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

  • No suitability assessment has been performed for any individual.
  • Market data may be delayed or inaccurate; figures are as of the analysis date.
  • Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
  • Forecasts are uncertain; past performance is not indicative of future returns.
  • The author or publisher may hold positions in securities mentioned.
  • Users should verify information against primary sources (company filings) before acting.
  • Investing involves risk of loss; there is no guarantee any target price is achieved.
  • Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.
Disclosures. This document is produced by MCH Advisory Services for informational and quantitative-research purposes only. It does not constitute investment, financial, legal or tax advice, nor an offer or solicitation to buy or sell any security. Price targets and probabilities are model outputs, not guarantees; past performance and backtested/simulated figures are not reliable indicators of future results. The author may hold positions in instruments mentioned and is not a registered financial adviser. Conduct your own due diligence and consult a qualified, registered adviser before making any investment decision.